Professor Joanna Wardlaw CBE talks about the new SVDs@target programme - Targeting interventions for small vessel disease to prevent stroke and dementia. This programme was funded by a 6 million euro grant from the European Union’s Horizon 2020 programme.
Evaluation of a new test to detect cognitive impairment in patients with small vessel disease stroke
Can we identify genetic risk factors that cause disease of small blood vessels in the brain?
Using genetics to understand why disease of the small blood vessels in the brain occurs
Stroke Association/BHF Joint Programme Grant
This research programme could substantially increase our understanding of how SVD develops, leading to new ways to investigate SVD and test drugs which may help treat it.
Apathy has a major effect of quality of life for a SVD sufferer; we have shown that for the patient it is more important in determining quality of life than is disability, such as weakness, from the stroke itself.
The Stroke Association's Keynote Lecture is a prestigious event that showcases the latest advancements being made in stroke research.
Find out more about our Keynote Lecture 2016